Detalhe da pesquisa
1.
Variant spectrum of von Hippel-Lindau disease and its genomic heterogeneity in Japan.
Hum Mol Genet
; 32(12): 2046-2054, 2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905328
2.
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
Hum Mol Genet
; 31(12): 1962-1969, 2022 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764097
3.
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.
Int J Clin Oncol
; 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797782
4.
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitors.
Cancer Sci
; 114(4): 1625-1634, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602227
5.
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
Int J Clin Oncol
; 28(11): 1530-1537, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552353
6.
Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.
Jpn J Clin Oncol
; 52(12): 1441-1445, 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093724
7.
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy.
Sci Rep
; 14(1): 5847, 2024 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38462660
8.
Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study.
Endocr Relat Cancer
; 30(7)2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37079309
9.
Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.
Cancer Med
; 12(16): 16837-16845, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403728
10.
The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer.
Curr Oncol
; 30(9): 8092-8110, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754502
11.
Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG.
Cancers (Basel)
; 15(7)2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046663
12.
Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism.
Genes (Basel)
; 13(7)2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35885987
13.
Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
JAMA Oncol
; 8(6): 871-878, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420638
14.
First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology.
Sci Rep
; 10(1): 20089, 2020 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208816